Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 4, 2026HRTSS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +3.1% | +11.7% | +7.9% | +12.9% | +24.8% | — | — | +53.9% |
| S&P 500 · VOO | +1.6% | −1.6% | 0.0% | +13.4% | +13.5% | +91.7% | +81.2% | — |
Key Statistics
Open all fund facts →- AUM
- $57M
- Expense ratio
- 0.99%
- Distribution yield
- 1.2%
- NAV
- $38.67
- Volume
- 4K
- Avg. volume 30D
- 2K
- High today
- $39.92
- Low today
- $39.45
- Previous close
- $38.64
- 52-week high
- $39.92
- 52-week low
- $32.00
- Our risk indicator
- 4/5
HRTS in One Breath
HRTS Among Its Peers
YTDEnd-of-day Nov 5, 2026 · 1 ETFs by YTD
$10,000 in HRTS
5Y$10,000 in HRTS became
$15,388
In the S&P 500 (VOO)
$17,585
Total return, dividends in · Nov 21, 2023 – Nov 4, 2026 · S&P 500 uses VOO
HRTS’s Top Holdings
TodayLLYEli Lilly &12.8%TMO5.1%MRK4.4%RHHBY4.3%KOD3.7%RVMD3.6%BBIO3.5%GILD3.4%UNH3.3%AZN.L3.2%DHR3.1%NOVN.SW3.1%CYTK3.0%JNJ3.0%NOVO-B.CO3.0%ABT3.0%VRTX2.8%ISRG2.4%ABBV2.3%MDT2.2%MCK2.1%SYK25 more
LLYEli Lilly &12.8%TMO5.1%MRK4.4%RHHBY4.3%KOD3.7%RVMD3.6%BBIO3.5%GILD3.4%UNH3.3%AZN.L3.2%DHR3.1%NOVN.SW3.1%35 more
Drug Manufacturers - GeneralBiotechnologyMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansMedical - InstrumentsOther
Tema HRTS · 47 holdings · tile size = share of the fund · as of Nov 4, 2026
What HRTS Holds
TodayDrug Manufacturers - General43.7%
LLY 12.8 · MRK 4.4 · RHHBY 4.3 · GILD 3.4 · AZN.L 3.2 · NOVN.SW 3.1 · JNJ 3.0
Biotechnology23.3%
KOD 3.7 · RVMD 3.6 · BBIO 3.5 · CYTK 3.0 · VRTX 2.8 · REGN 1.3 · MDGL 1.0
Medical - Devices12.0%
ABT 3.0 · MDT 2.2 · SYK 2.0 · EW 1.4 · DXCM 1.3 · BSX 1.1 · SOON.SW
Medical - Diagnostics & Research9.3%
TMO 5.1 · DHR 3.1 · ILMN 1.1
Medical - Healthcare Plans5.3%
UNH 3.3 · CNC 1.9
Medical - Instruments & Supplies2.4%
ISRG 2.4
Medical - Distribution2.1%
MCK 2.1
Tema HRTS · share of the fund by industry · as of Nov 4, 2026
Eli’s Share of HRTS
Today12.8%
$128 of every $1,000 in HRTS is Eli
Eli held by HRTS
$7.3M
Tema HRTS · each square = $10 of $1,000 · as of Nov 4, 2026
HRTS’s Size vs Its Peers
Today$57.2Mthe largest ETF
AUM · HRTS and the 0 largest peers · Nov 5, 2026
HRTS Fee per $100 vs Peers
TodayExpense ratio · peers · Nov 5, 2026
Inside HRTS
47 holdings · as of Nov 4, 2026HRTS
Tema Heart & Health ETF
TodayDrug Manufacturers - General43.7%LLY12.8%MRK4.4%RHHBY4.3%GILD3.4%AZN.L3.2%NOVN.SW3.1%JNJ3.0%NOVO-B.CO3.0%ABBV2.3%BMYAMGNBiotechnology23.3%KOD3.7%RVMD3.6%BBIO3.5%CYTK3.0%VRTX2.8%REGNMDGLSTOKXENEARWRMBXSRRKGMABVKTXMedical - Devices12.0%ABT3.0%MDTSYK2.0%EWDXCMBSXSOON.PODDMedical - Diagnostics9.3%TMO5.1%DHR3.1%ILMNMedical - Healthcare Plans5.3%UNH3.3%CNCMedical - Instruments2.4%ISRGMCKTEVACTY
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 12.78% |
| 2 | TMO | Thermo Fisher Scientific | 5.10% |
| 3 | MRK | Merck & | 4.36% |
| 4 | RHHBY | Roche AG | 4.26% |
| 5 | KOD | Kodiak Sciences | 3.73% |
| 6 | RVMD | Revolution Medicines | 3.62% |
| 7 | BBIO | Bridgebio Pharma | 3.52% |
| 8 | GILD | Gilead Sciences | 3.41% |
| 9 | UNH | Unitedhealth Group | 3.35% |
| 10 | AZN.L | Astrazeneca | 3.19% |
Drug Manufacturers - GeneralBiotechnologyMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansMedical - InstrumentsMedical - DistributionDrug Manufacturers - SpecialtyOther
Tema HRTS · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 75.2%
How It Compares
HRTS
Tema Heart & Health ETF’s Peers
1YHRTS has no close peers in our data yet: […]
Similar peers · Past-year and ytd returns · as of Nov 5, 2026 · sorted by AUM
Head to Head
HRTS vs VOO
1YHRTS · Tema Heart & Health
+24.8%
VOO · S&P 500
+13.5%
Gap
11.3 pts
Tema HRTS and Vanguard VOO · 1Y total return · as of Nov 5, 2026
HRTS vs Its Peer Average
YTDHRTSAvsBPeer average
1D+3.1%[…]
1M+11.7%[…]
3M+7.9%[…]
YTD+12.9%[…]
1Y+24.8%[…]
0–0level
0 peers · each row scaled to its leader
The Details
HRTS
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y16.85%
Deepest drop · 1Y−11.0%
Lowest point · 5Y0.0%
52-week range
$39.84
$32.00−0.2% from the high$39.92
Tema HRTS · past-year price moves · as of Nov 5, 2026
HRTS
Fund Facts
Today2023launched Nov 20
Tracks[…]
Exchange · CUSIPNASDAQ · 87975E883
StructureETF
Leverage1x
Cost on $10,000$99 a year
Go deeper
Tema HRTS · fund facts · as of Nov 5, 2026
HRTS
Payouts by Year
2Y$0.47per share, Dec 2025
Distribution yield1.2%
Paid[…]
Latest ex-date · paidDec 10 · Dec 11, 2025
2 payouts added up$0.94 a share
Tema HRTS · distributions by ex-date · 2024–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗SEC reported portfolio · 2026-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗SEC reported portfolio · 2025-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-02-28 ↗SEC reported portfolio · 2024-11-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-08-31 ↗SEC reported portfolio · 2024-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-02-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-11-30 ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$38.67
Premium / discount[…]
Median spread · 30D[…]
Volume today4K
Average volume · 30D2K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.99%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$99.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | $0.47 |
| Dec 11, 2024 | Dec 12, 2024 | $0.47 |
Issuer contentFrom TemaHear the strategy from the people behind HRTS.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →